Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

BCG Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Condition:   Tuberculosis Interventions:   Biological: BCG vaccine SSI;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

BCG Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Condition:   Tuberculosis Interventions:   Biological: BCG vaccine SSI;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

BCG Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Condition:   Tuberculosis Interventions:   Biological: BCG vaccine SSI;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

BCG Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Condition:   Tuberculosis Interventions:   Biological: BCG vaccine SSI;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

BCG Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Condition:   Tuberculosis Interventions:   Biological: BCG vaccine SSI;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

BCG Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Condition:   Tuberculosis Interventions:   Biological: BCG vaccine SSI;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

BCG Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Condition:   Tuberculosis Interventions:   Biological: BCG vaccine SSI;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

BCG Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Condition:   Tuberculosis Interventions:   Biological: BCG vaccine SSI;   Biological: Placebo Sponsor:   Bill & Melinda Gates Medical Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Intravenous Treatment of Tuberculosis
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol Sponsor:   Yuria-Pharm Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials